tiprankstipranks
Sagimet Biosciences price target lowered to $31 from $32 at JMP Securities
PremiumThe FlySagimet Biosciences price target lowered to $31 from $32 at JMP Securities
17d ago
Sagimet Biosciences participates ik,on No
Premium
The Fly
Sagimet Biosciences participates ik,on No
1M ago
Sagimet Biosciences presents clinical denifanstat, preclinical FASN inhibitor da
Premium
The Fly
Sagimet Biosciences presents clinical denifanstat, preclinical FASN inhibitor da
1M ago
Sagimet Biosciences completes End-of-Phase 2 meeting with FDA on denifanstat
PremiumThe FlySagimet Biosciences completes End-of-Phase 2 meeting with FDA on denifanstat
2M ago
Sagimet Biosciences to present Phase 2b data of denifanstat at AASLD 2024
Premium
The Fly
Sagimet Biosciences to present Phase 2b data of denifanstat at AASLD 2024
2M ago
Sagimet Biosciences announces Phase 2b FASCINATE trial met primary endpoint
Premium
The Fly
Sagimet Biosciences announces Phase 2b FASCINATE trial met primary endpoint
2M ago
Sagimet Biosciences price target lowered to $32 from $48 at JMP Securities
PremiumThe FlySagimet Biosciences price target lowered to $32 from $48 at JMP Securities
4M ago
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
Premium
The Fly
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
4M ago
Sagimet Biosciences reports Q2 EPS (25c), consensus (33c)
Premium
The Fly
Sagimet Biosciences reports Q2 EPS (25c), consensus (33c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100